alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information
extracted from the fiscal year end 10-KSB for the fiscal year
ending August 31, 2000 and is qualified in its entirety by
reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          AUG-31-2000
<PERIOD-END>                               AUG-31-2000
<CASH>                                       1,359,692
<SECURITIES>                                         0
<RECEIVABLES>                                  515,581
<ALLOWANCES>                                    54,032
<INVENTORY>                                          0
<CURRENT-ASSETS>                             2,086,381
<PP&E>                                       2,722,797
<DEPRECIATION>                               1,649,589
<TOTAL-ASSETS>                               4,089,254
<CURRENT-LIABILITIES>                          710,146
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       674,533
<OTHER-SE>                                   2,441,744
<TOTAL-LIABILITY-AND-EQUITY>                 4,089,254
<SALES>                                      3,605,249
<TOTAL-REVENUES>                             3,605,249
<CGS>                                        1,157,089
<TOTAL-COSTS>                                1,157,089
<OTHER-EXPENSES>                             2,889,145
<LOSS-PROVISION>                             (252,846)
<INTEREST-EXPENSE>                              21,161
<INCOME-PRETAX>                              (395,758)
<INCOME-TAX>                                       800
<INCOME-CONTINUING>                          (396,558)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (396,558)
<EPS-BASIC>                                     (0.03)
<EPS-DILUTED>                                   (0.03)


</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - [Docket No. FDA-2010-N-0541]

# AGENCY:

Food and Drug Administration, HHS.

# ACTION:

Notice.

# SUMMARY:

The Food and Drug Administration (FDA) is announcing that a collection of information entitled “Guidance for Industry on Special Protocol Assessment” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

# FOR FURTHER INFORMATION CONTACT:

                        Elizabeth Berbakos, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville, MD 20850, 301-796-3792,                         *Elizabeth.Berbakos@fda.hhs.gov.*

# SUPPLEMENTARY INFORMATION:

                    In the                     **Federal Register**                     of October 26, 2010 (75 FR 65636), the Agency announced that the proposed information collection had been submitted to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0470. The                           ( print page 14405)                        approval expires on February 28, 2014. A copy of the supporting statement for this information collection is available on the Internet at                     *http://www.reginfo.gov/​public/​do/​PRAMain.*

Dated: March 10, 2011.

Leslie Kux,

Acting Assistant Commissioner for Policy.

[FR Doc. 2011-6092 Filed 3-15-11; 8:45 am]

BILLING CODE 4160-01-P
### SUBCHAPTER C—OREGON CASCADES RECREATION AREA
Mr. Stephen B. Etsitty Executive Director UNITED STATES ENVIRONMENTAL PROTECT I O N AGENCY WASHINGTON , D
. C. 20460



## A

P

R 

## 2 0 2015

N avajo Nat ion Environmental Protection Agency Navajo Nation

- B u ilding # 2318 P .O
. Box 339 Window Rock, Nava j o Natio n , Arizona 865 1 5 Dear Mr. Ets itty : OFFIC E O F A IR AND RA D IATIO N

Thank you for your letter , dated April 2 , 2015, req uesting two meetings with the U.S. Env ironmental Protection Agency including a techn ical meeting and a government-to-government co n su ltation on the E PA's proposed Carbon Pollution Emission Guidelines for Existing Stationary Sources; EGUs in Indian Country and U.S. Territories; Multi-Jurisdictional Partnerships. You specificall y asked that the meeti n gs occur on April 27, 20 1 5, in Washington, D.C. We are agreeable and look forward to meeting with you on this date. I plan to attend the government- to-government mee t ing in person . In addition, several seni or management officials from OAR and Region 9 plan to attend t he consultation as well as the technical meeti ng on the same day. They will attend either in person or v i a co n fere n ce calL In your letter, you expresse d interest in d i scussing the fo ll ow ing issues with EPA at the technical meeti ng : I) Baseline year 2) Heat rate imp r ovements pertaining to Navajo Generating Stati on and Four Corners Power Plant 3) Early compl i ance option 4) Renewable energy development on the Navajo Nation. Dur i ng the government-to-government consultation, you state you would like to discuss the fo ll owing with EPA:
. I) Parity glidepath deve loped by the Navajo Nati on regarding end use energy efficiency (application of Building Block 4 to the Navajo Nation) 2) Navajo Nation 's comments on the proposed rule and supplemental rule

I n terne t Add ress ( U R L ) • h ltp : /N IWw.epa.gov Recycled/Recyclable • P r i n ted w i th Veget able O i l B as e d Inks on 1 00% Postcon sumer. P rocess Chlo ri n e Fr ee Recycl ed Pape rWe look forward to disc us sing these issues with you on April27, 2015. In the meantime if you have any questions, please contact Pat Childers of my staff at (202) 564-1082 or childers.pat@epa .gov . Sincerely,

Janet G. McCabe Acting Assistant Admi ni strator
<PAGE>

                                                                    EXHIBIT 23.1

              Consent of Independent Certified Public Accountants

Advanced Nutraceuticals, Inc.
106 South University Blvd., Unit 14
Denver, CO 80209

We have issued our report dated December 26, 2001, accompanying the consolidated
financial statements included in the Annual Report of Advanced Nutraceuticals,
Inc. on Form 10-K for the year ended September 30, 2001.  We hereby consent to
the incorporation by reference of said report in the Registration Statement for
Advanced Nutraceuticals, Inc. (the successor to Nutrition For Life
International, Inc.) on Form S-8 (File No. 33-99366, effective December 5,
1995).

Grant Thornton LLP
Houston, Texas
December 26, 2001
### Disposition Comments Docket No: FAA-2015-3970 

### 0 These comments are in response to an SNPRM 

### Directorate ID: 2015-SW-006-AD Originating Office Tracking No
. : 2014-0145R I 

### Next Step: 

### 181 FRAN 

### D SNPRM 

### 0 No Comments/Only Supporti ve Comments Received 

## -If this box is check ed

, no signatures are required. No 

### Has the referenced service information been revised since the NPRM was issued ? If yes, list latest revision and attach a copy. N ote that changes be yond the scope of th e pre viously published N PRMwill require a n ew notice
. Contact the Directorate focalpoint for guidance. 

### L_atc st Revision. Instructions: Summ arize all comments by issue (not by commenter) and provide your reco mmended resolution of each issue. All comments relating to t he same issue should be discussed together. Do not list all of the issue s from one commenter togethe r. If changes to the AD are required based on the comments received , explain why and describe in detail what change(s) you recommend
. Reference FAA-IR-M-8040.1 C Chapter 9. 

### ISSUE 1: Select on e of thefollowing : 

### Choose one. 

## If

other , e xplain: Commenter(s): Mike May , Airbus Helicopters What change to the AD action is requested? Add an option for a pilot to perform an external check for cracks in the Fenestron Junction Frame
. Why is the change requested or how is it justified? Operators would benefit with a check that can be performed by the pilot, that has the same level of safety Do we agree? No If 

### YES, we agree because 

### Insert jus1ifieation Make the following changes to the AD: List 

### any changes to the AD If 

### PARTIALLY AGREE , we agree with 

### Insert text because Insert 

### justi tical 

### ion We disagree with Insert 

### text because Insert 

### justification Make the following changes to the AD: 

### List any changes to the 

### AD If NO , we don ' t agree becau s e the proposed change is premature in that there is still an active investigation into the cause of the fatigue crack.



### Page 1 

### of2Signature Section Signature indicates concurrence with this action. Originating Office Tracking No.: 2014-0145RI (June 13, 2014) 

# tk1J
1 Da4e ASE Printed Name: Robert Grant

Bra Date



### Page 2 of2
Exhibit 10.8


Dear Peter:

As discussed, effective November 15, 2004 (the "Effective Date"), you will
assume the position of Executive Vice President Retail Development, reporting to
Brian Piwek, President and Chief Operating Officer.

The Company recognizes that this change has given you Good Reason to terminate
your employment pursuant to Paragraph 8(a) of the Employment Agreement between
you and The Great Atlantic & Pacific Tea Company, Inc., made and entered into on
October 2, 2002 (the "Agreement").

Whereas, in order to induce you not to terminate your employment within the 3
month period immediately following the Effective Date, and whereas, you would
prefer not to terminate your employment, it is agreed that with respect to your
reassignment on November 15, 2004, the 3-month period in the last sentence of
Paragraph 8(a) of the Agreement shall be changed to a 9-month period.

Except as indicated above, the Agreement, its terms and conditions shall remain
in full force and effect.

If the terms outlined above are acceptable, please sign below and return to me
an original executed copy of this letter agreement. Upon execution of this
letter agreement, the Agreement shall be deemed amended in accordance with
Paragraph 28 thereof.

                             Sincerely,

                             The Great Atlantic & Pacific Tea Company, Inc.


                             By: /s/Allan Richards
                                 -------------------------------------
                                 Allan Richards




Agreed to and accepted this 10th day of November, 2004.


/s/Peter Jueptner
------------------------------
Peter Jueptner
SAMHSA and NIMH gather 14 researchers with aim of improving SMI treatment and

recovery

Substance Abuse and Mental Health Services Administration (SAMHSA) partnered with the National 

Institute of Mental Health (NIMH) to bring together 14 eminent mental health researchers to participate in 

an expert panel meeting, “Research Opportunities for Improving Treatment Interventions and Recovery 

Services for Adults with SMI.” 

This meeting was a first step to “developing a priority research agenda for SED/SMI prevention, 

diagnosis, treatment, and recovery services” which you may recognize as recommendation 3.8 in 

the Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC) Report to 

Congress. The meeting focused on research related to better treatment interventions and recovery 

services for adults (ages 18-64) with established schizophrenia spectrum disorders. 

The event opened with remarks from Dr. Anita Everett, Chief Medical Officer, SAMHSA, and 

Dr. Robert Heinssen, Director, Division of Services and Intervention Research, NIMH. The 

format of the meeting was divided into four, over-arching topic areas: 1) pharmacological 

approaches, 2) treatment of comorbid medical conditions, 3) psychosocial interventions for 

illness management aimed at improving treatment interventions and recovery services and 4) 

future directions for research and practice. Each topic area began with formal, 35-minute 

presentations followed by a group discussion of key issues. 

The presentations summarized available 

scientific evidence, outlined gaps in 

knowledge, and identified research 

activities that could address areas of 

uncertainty for treating SMI. Panelists 

identified gaps in knowledge around key

topics including pharmacologic options for 

treating negative symptoms and cognitive 

impairments, peer interventions, cognitive 

remediation, and illness self-management 

programs and recovery and social isolation. 

They also reviewed the need for better 

practices that keep people with SMI out of 

the criminal justice system, in stable housing, and that reduce health care disparities for

racial/ethnic populations. Panelists acknowledged that we must respect the importance of both 

evidence and implementation. There are interventions known to be effective in treating 

individuals who have SMI, but they are often not widely implemented or implemented with 

fidelity. Panelists asserted the field needs to evaluate strategies to deploy, to sustain and to 

enhance effective interventions in community settings, to develop and to test approaches to 

overcome barriers to implementing and sustaining treatment, and to incorporate strategies that 

address workforce training and maintenance.

The observations and recommendations from the meeting are being organized and will be 

incorporated into the NIMH Strategic Plan for Research, 2020-2025, and will influence NIMH 

funding opportunities in the fall. Future panels aimed at developing a priority research agenda for 

SMI will build off of this panel’s work.
§ 115.386 Sexual abuse incident reviews. ( a ) The facility shall conduct a sexual abuse incident review at the conclusion of every sexual abuse investigation, including where the allegation has not been substantiated, unless the allegation has been determined to be unfounded.
( b ) Such review shall ordinarily occur within 30 days of the conclusion of the investigation.
( c ) The review team shall include upper-level management officials, with input from line supervisors, investigators, and medical or mental health practitioners.
( d ) The review team shall: ( 1 ) Consider whether the allegation or investigation indicates a need to change policy or practice to better prevent, detect, or respond to sexual abuse;
( 2 ) Consider whether the incident or allegation was motivated by race; ethnicity; gender identity; lesbian, gay, bisexual, transgender, or intersex identification, status, or perceived status; or, gang affiliation; or was motivated or otherwise caused by other group dynamics at the facility;
( 3 ) Examine the area in the facility where the incident allegedly occurred to assess whether physical barriers in the area may enable abuse;
( 4 ) Assess the adequacy of staffing levels in that area during different shifts;
( 5 ) Assess whether monitoring technology should be deployed or augmented to supplement supervision by staff; and
( 6 ) Prepare a report of its findings, including but not necessarily limited to determinations made pursuant to paragraphs (d)(1) through (d)(5) of this section, and any recommendations for improvement and submit such report to the facility head and PREA compliance manager.
( e ) The facility shall implement the recommendations for improvement, or shall document its reasons for not doing so.
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr., Chief Justice

Michael F. Cavanagh

Stephen J. Markman

Mary Beth Kelly

Brian K. Zahra

Bridget M. McCormack

David F. Viviano, Justices

I, Larry S. Royster, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

 February 28, 2014

h0224

Order 

Clerk

February 28, 2014

147866 & (18)(19)

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff-Appellee,

v SC: 147866

COA: 315348

Wayne CC: 02-014742-FC

ROGER YOUNG,

Defendant-Appellant.

_________________________________________/

On order of the Court, the motion to file supplemental brief is GRANTED. The 

application for leave to appeal the August 29, 2013 order of the Court of Appeals is 

considered, and it is DENIED, because the defendant’s motion for relief from judgment 

is prohibited by MCR 6.502(G). The motion for miscellaneous relief to enter a 

confession of error is DENIED.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
"THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF GEORGIA-PACIFIC CORPORATION FOR THE 12 MONTHS ENDED
DECEMBER 31, 1995, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS."
</LEGEND>
<MULTIPLIER> 1,000,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               DEC-31-1995
<CASH>                                              11
<SECURITIES>                                         0
<RECEIVABLES>                                      974
<ALLOWANCES>                                        25
<INVENTORY>                                      1,446
<CURRENT-ASSETS>                                 2,595
<PP&E>                                          12,576
<DEPRECIATION>                                   6,563
<TOTAL-ASSETS>                                  12,335
<CURRENT-LIABILITIES>                            1,762
<BONDS>                                          4,704
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            73
<OTHER-SE>                                       3,446
<TOTAL-LIABILITY-AND-EQUITY>                    12,335
<SALES>                                         14,292
<TOTAL-REVENUES>                                14,292
<CGS>                                           10,037
<TOTAL-COSTS>                                   10,037
<OTHER-EXPENSES>                                   762
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 395
<INCOME-PRETAX>                                  1,697
<INCOME-TAX>                                       679
<INCOME-CONTINUING>                              1,018
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,018
<EPS-PRIMARY>                                    11.18
<EPS-DILUTED>                                    11.18
        

</TABLE>
### §77o. Liability of controlling persons

#### (a) Controlling persons

Every person who, by or through stock ownership, agency, or otherwise, or who, pursuant to or in connection with an agreement or understanding with one or more other persons by or through stock ownership, agency, or otherwise, controls any person liable under sections 77k or 77l of this title, shall also be liable jointly and severally with and to the same extent as such controlled person to any person to whom such controlled person is liable, unless the controlling person had no knowledge of or reasonable ground to believe in the existence of the facts by reason of which the liability of the controlled person is alleged to exist.

#### (b) Prosecution of persons who aid and abet violations

For purposes of any action brought by the Commission under subparagraph (b) or (d) of section 77t of this title, any person that knowingly or recklessly provides substantial assistance to another person in violation of a provision of this subchapter, or of any rule or regulation issued under this subchapter, shall be deemed to be in violation of such provision to the same extent as the person to whom such assistance is provided.

(May 27, 1933, ch. 38, title I, §15, 48 Stat. 84; June 6, 1934, ch. 404, title II, §208, 48 Stat. 908; Pub. L. 111–203, title IX, §929M(a), July 21, 2010, 124 Stat. 1861.)

#### **Editorial Notes**

#### Amendments

2010—Pub. L. 111–203 designated existing provisions as subsec. (a), inserted heading, and added subsec. (b).

1934—Act June 6, 1934, exempted from liability controlling persons having no knowledge or reasonable grounds for belief.

#### **Statutory Notes and Related Subsidiaries**

#### Effective Date of 2010 Amendment

Amendment by Pub. L. 111–203 effective 1 day after July 21, 2010, except as otherwise provided, see section 4 of Pub. L. 111–203, set out as an Effective Date note under section 5301 of Title 12, Banks and Banking.
Exhibit 32






CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND INTERIM CHIEF FINANCIAL OFFICER


PURSUANT TO 18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the quarterly report on Form 10-Q of Overhill Farms, Inc. (the “Company”) for the quarter ended March 28, 2010 (the “Report”), the undersigned hereby certify in their capacities as Chief Executive Officer and Interim Chief Financial Officer of the Company, respectively, pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:




1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and




2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




Date:  May 6, 2010

By:
/s/ James RudisJames RudisChief Executive Officer(principal executive officer)Date:  May 6, 2010

By:
/s/ Tracy E. QuinnTracy E. QuinnInterim Chief Financial Officer(principal financial officer)




A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
### §7605. Content of advertisements and other representations

Any person that engages in the manufacture, processing, assembly, sale, offering for sale, or distribution of contact lenses may not represent, by advertisement, sales presentation, or otherwise, that contact lenses may be obtained without a prescription.

(Pub. L. 108–164, §6, Dec. 6, 2003, 117 Stat. 2026.)

#### **Statutory Notes and Related Subsidiaries**

#### Effective Date

Section effective 60 days after Dec. 6, 2003, see section 12 of Pub. L. 108–164, set out as a note under section 7601 of this title.
#### § 115.162 Agency protection duties.

When an agency learns that a detainee is subject to a substantial risk of imminent sexual abuse, it shall take immediate action to protect the detainee.